Meet Jenya

Dr. Jenya Antonova is PhD-trained health economist with deep expertise in patient-reported outcomes (PRO) and (COA). With 15+ years of experience in the pharmaceutical and biotech industries, Dr. Antonova has honed a keen ability to develop and implement strategies that enhance evidence generation and elevate the value proposition of health technologies through the strategic use of PRO, COA, and health economic evidence. She is recognized for her holistic perspective, deftly integrating cross-functional insights to create robust, multi-faceted strategies that address needs of multiple stakeholders.

 

Since 2022, Jenya is an independent health economist and a trusted partner to a diverse client base, guiding them to not just meet but exceed their goals in demonstrating the value of their technologies. This strategic agility enables her to adeptly address the nuanced needs of various stakeholders, including regulatory and HTA agencies, payers, healthcare providers, and patients, ensuring that every resource is optimized for maximum impact. She delivers a practical approach, balancing analytical rigor, strategic foresight, and the current budgetary constraints.

 

Dr. Antonova's research has been recognized with publication awards at prestigious national and international conferences, showcasing her commitment to excellence. Her work exemplifies the intersection of rigorous analysis, strategic innovation, and clear scientific messaging, solidifying her reputation as a practical perfectionist with strong strategic agility and excellent publication skills.

​

Learn about services.

​

Go back to homepage.